Page last updated: 2024-10-18

dihydroxyphenylalanine and Craniopharyngioma, Adamantinous

dihydroxyphenylalanine has been researched along with Craniopharyngioma, Adamantinous in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frantz, AG1
Kleinberg, DL1
Noel, GL1
Esposito, V1
Bellastella, A1
D'Alessandro, B1
Iacono, G1
Montano, A1

Reviews

1 review available for dihydroxyphenylalanine and Craniopharyngioma, Adamantinous

ArticleYear
Studies on prolactin in man.
    Recent progress in hormone research, 1972, Volume: 28

    Topics: Acromegaly; Biological Assay; Craniopharyngioma; Dihydroxyphenylalanine; Estrogens; Female; Gynecoma

1972

Other Studies

1 other study available for dihydroxyphenylalanine and Craniopharyngioma, Adamantinous

ArticleYear
[Behavior of somatotropic hormone (HCH) after stimulation with L-arginine and L-Dopa in a subject operated for craniopharyngioma].
    Bollettino della Societa italiana di biologia sperimentale, 1973, May-30, Volume: 49, Issue:10

    Topics: Adolescent; Arginine; Craniopharyngioma; Dihydroxyphenylalanine; Female; Growth Hormone; Humans; Pit

1973